




Quantitation of angiogenesis and antiangiogenesis in vitro  
 
Angiogenesis is defined as sprouting of new capillaries from pre-existing ones. Angiogenesis 
is a pre-requisite for growth and differentiation of organs and tissues and is involved in many 
pathological processes, for example growth and metastasis of tumours.  
Up to now numerous in vivo- and in vitro-models of angiogenesis have been developed in 
order to identify and analyse pro- and antiangiogenic factors. In these models, the effects of 
the substances tested were quantified in a few phases of angiogenesis only.  
 
The aim of the present study was to establish a method to quantify angiogenesis and 
antiangiogenesis in vitro in order achieve a replacement and complementary method 
comprising all stages of the angiogenic cascade. Furthermore, routinely accomplishment of 
quantitation should be possible for different investigators with a maintainable effort of time 
and costs.  
 
Endothelial cells derived from the bovine corpus luteum have been incubated in a selective 
medium, and the resulting angiogenic reaction of these cells was examined by phase 
contrast microscopy. In the course of in vitro angiogenesis, endothelial cells showed 
characteristic changes in their cellular morphology, i.e. sprouting, linear side by side 
arrangement and three-dimensional organisation in capillary-like structures. Subsequently, 
these phases of angiogenesis in vitro have been divided into eight strictly defined stages. 
Thus, in contrast to previously described in vivo and in vitro models, quantitation of the 
temporal course of angiogenesis and antiangiogenesis was established.  
 
The reproducibility of quantitation of angiogenesis was verified by examination of the defined 
stages by different persons and investigation of homogeneity of the course of angiogenesis 
in different culture dishes. Assessment of the stages of angiogenesis by two different 
investigators showed only minimal variances, and can therefore be established by a single 
investigator. The statistical evaluation of the course of angiogenesis in different culture 
dishes assessed by the defined stages of angiogenesis showed that a small sample size 
only is needed for quantitation of angiogenesis in this model. Thus, quantitation of 
angiogenesis and antiangiogenesis is not only time-efficient, but the method may also be 





Within the scope of this study, as previously described in vivo, ex vivo and in vitro-models 
employed for identification and testing of pro- and anti-angiogenic factors were compared in 
extension. 
 
In case an in vitro-model should be employed to reduce or replace animal testing, 
comparability to angiogenesis in vivo is essential and was established by examination of 
several characteristics of the cultured endothelial. The morphometry of capillary-like 
structures in vitro showed an increase of the area occupied, the length and the number of 
branching points in the course of angiogenesis.  
The ultrastructural changes of the endothelial cells in the course of angiogenesis in vitro 
showed analogies to angiogenesis in vivo, for example, a change in the number of cell 
organelles like mitochondria and endoplasmic reticulum occurred. Above all, an essential 
attribute of differentiated endothelial cells, their polarisation in the context of angiogenesis, 
was observable. However, the presence of extracellular matrix inside the capillary-like 
structures suggested a converted polarity of endothelial cells.  
 
The immunocytochemical investigation of collagen type IV demonstrated that endothelial 
cells secreted a characteristic component of the basal membrane.  
The appearance of apoptotic endothelial cells, a sign of capillary maturation in vivo, was also 
observed in cultured endothelial cells. According to the converted polarity of the endothelial 
cells, apoptosis was detected in cells at the exterior side of capillary-like structures, where 
cells lost contact to the extracellular matrix.  
 
In this study, proangiogenic effects of “Vascular Endothelial Growth Factor” (VEGF) and 
“Fibroblast Growth Factor-2” (FGF-2) were established and quantified by the newly 
developed method. A particularly noteworthy result was the observation that VEGF induces 
formation of endothelial spheroids in vitro, equivalent to large-calibre vessels in vivo. 
Additionally, the reports from in vivo studies of stimulation of chemokinesis induced by    
FGF-2, and chemotaxis induced by VEGF, respectively, were verified. Examination and 
quantitation of the angiogenesis-inhibitors Angiostatin and Suramin detected that 
Angiostatin-induced antiangiogenesis resulted in an ‘inverse’ angiogenesis. Suramin, on the 
other hand, initially resulted in increased angiogenesis. Long-term incubation ultimately 
resulted in disintegration of endothelial structures and thus established the antiangiogenic 
properties of Suramin.  
 
In conclusion, the present model allows a viable quantitation of angiogenesis and 
antiangiogenesis in vitro. It can be employed either in trial studies of potential angiogenic and 
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antiangiogenic substances, respectively, or in the investigation of their essential cellular and 
molecular mechanisms and may thus provide an efficient method to reduce, refine and 
replace animal testing. 
